Hydroxychloroquine During Pregnancy: A Review of Retinal Toxicity in the Newborns;Toxicité rétinienne de l'hydroxychloroquine chez le nouveau-né exposé in utero

Therapie

Volumn 68, Issue 1, 2013, Pages 43-47

  Tarfaoui, Naoual ^a   Autret Leca, Elisabeth ^a   Mazjoub, Samuel ^a,b   Cissoko, Hawaré ^a   Jonville Béra, Annie Pierre ^a  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

^b UNIVERSITÉ DE TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE;

ARTICLE; DISEASE ASSOCIATION; EYE TOXICITY; HUMAN; MATURITY; NEWBORN DISEASE; PATIENT MONITORING; PHOTOSTIMULATION; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; REMOTE SENSING; RETINA DISEASE;

EID: 84875132766     PISSN: 00405957     EISSN: 19585578     Source Type: Journal    
DOI: 10.2515/therapie/2013003     Document Type: Article

References (38)

1. ® 2011
2. Costedoat-Chalumeau N, Amoura Z, Duhaut P, et al. Safety of hydroxychloroquine in pregnancy patients with connective tissue disease. A study of 133 cases compared with a Control Group. Arthritis Rheum 2003; 48: 3207-14
3. Sperber K, Hom C, Chao CP, et al. Systematic review of hydroxychloroquine use in pregnant patients with autoimmunes diseases. Pediatric Rheumatology 2009; 7: 9
4. Costedoat-Chalumeau N, Amoura Z, Aymard G, et al. Evidence of transplacental passage of hydroxychloroquine in humans. Arthritis Rheum 2002; 46: 1123-4 (Pubitemid 34303828)
5. Buchanan NM, Toubi E, Khamashta MA, et al. Hydroxychloroquine and lupus pregnancy: review of series of 36 cases. Ann Rheum Dis 1996; 55: 486-8 (Pubitemid 26249027)
6. Motta M, Tincani A, Faden D, et al. Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation. J Perinatol 2005; 25: 86-9 (Pubitemid 40277379)
7. Levy RA, Vilela VS, Cataldo MJ, et al. Hydroxychloroquine in lupus pregnancy: double-blind and placebo-controlled study. Lupus 2001; 10 (6): 401-4 (Pubitemid 32578614)
8. Parke AL, Rothfield NF. Antimalarial drugs in pregnancy the North American experience. Lupus 1996 Jun; 5 suppl 1: S67-69 (Pubitemid 26196746)
9. Clowse MEB, Magder L, Witter F, et al. Hydroxychloroquine in lupus pregnancy. Arthritis & Rheum 2006; 54: 3640-7 (Pubitemid 44737176)
10. Klinger G, Morad Y, Westall CA, et al. Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases. Lancet 2001; 358: 813-4 (Pubitemid 32868737)
11. Cimaz R, Brucato A, Meregalli E, et al. Electroretinograms of children born to mothers treated with hydroxychloroquine during pregnancy and breast-feeding: comment on the article by Costedoat-Chalumeau et al. Arthritis Rheum 2004; 50: 3056-7
12. Costedoat-Chalumeau N, Amoura Z, Sebbough D, et al. [Reply] Arthritis Rheum. 2004; 50 (9): 3057-8
13. Renault F, Flores-Guevara R, Renaud C, et al. Visual neurophysiological dysfunction in infants exposed to hydroxychloroquine in utero. Acta Paediatrica 2009; 98: 1500-3
14. Ingster-Moati I, Albuisson E. Visual neurophysiological dysfunction in infants exposed to hydroxychloroquine in utero. [letter] Acta Paediatrica 2010; 99: 4-7
15. Renault F, Flores-Guevara R, Renaud C, et al. Visual neurophysiological dysfunction in infants exposed to hydroxychloroquin in utero. [Reply] Acta Paediatrica 2010; 99: 4-7
16. Udalova LD. The effect of chloroquine on the embryonal development of rats. Russ Pharmacol Toxicol 1967; 30: 114-7
17. Paufique L, Magnard P. Retinal degeneration in 2 children following preventive treatment of mother during pregnancy. Bull Soc Ophtalmol Fr 1969; 69: 466-7
18. Hobbs HE, Sorsby A, Freedman A. Retinopathy following chloroquine therapy. Lancet 1959; 2 (7101): 478-80
19. Bernstein HN. Ophtalmologic considerations and testing in patients receiving long-term antimalarial therapy. Am J Med 1983; 75 (1A): 25-33
20. Stepien KE, Han DP, Schell J, et al. Spectral-domain optical coherence tomography and adaptative optics may detect hydroxychloroquine retinal toxicity before symptomatic vision loss. Trans Am Ophtalmol Soc 2009; 107: 28-34
21. Chen E, Brown DM, Benz MS, et al. Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the flying saucer sign). Clin Ophtalmol 2010; 4: 1151-8
22. Ulberg S. Accumulation of chorioretinotoxic drugs in the fetal eye. Nature 1970; 227: 1257-8
23. Mahon GJ, Anderson HR, Gardiner TA, et al. Chloroquine causes lysosomal dysfunction in neural retina and RPE: implications for retinopathy. Curr Eye Res 2004; 28: 277-8
24. Boya P, Gonzales-Polo RA, Ponçet D, et al. Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene 2003; 22 (25): 3927-36 (Pubitemid 36819666)
25. Sundelin SP, Terman A. Differents effects of chloroquine and hydroxychloroquine on lysosomal function in cultured retinal pigment epithelial cells. APMIS 2002; 110: 481-9 (Pubitemid 34856490)
26. Ingster-Moati I, Orssaud C. Protocole de surveillance ophtalmologique des patients traités par antipaludéens de synthèse ou par vigabatrin au long cours. J Fr Ophtalmol 2009; 32: 83-8
27. Strauss O. The retinal pigment epithelium in visual function. Physiol Rev 2005; 85 (3): 845-81 (Pubitemid 40885218)
28. Wassell J, Davies S, Bardsley W, et al. The photoreactivity of the retinal age pigment lipofuscin. J Biol Chem 1999; 274 (34): 23828-32
29. Mavrikakis I, Sfikakis PP, Mavrikakis E, et al. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal. Ophtalmology 2003; 110: 1321-6 (Pubitemid 36842465)
30. Wolfe F, Marmor MF. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care & Res (Hoboken) 2010; 62: 775-84
31. Marmor MF, Kellner U, Lai TYY, et al. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophtalomology 2011; 118: 415-22
32. ®) sur l'électrorétinogramme. J Fr Ophtalmol 2004; 27 (9): 1007-12 (Pubitemid 39556828)
33. Rynes RI. Ophtalmologic safety of long-term hydroxychloroquine sulfate treatment. Am J Med 1983; 75 (1A): 35-9 (Pubitemid 13025978)
34. Fulton AB, Dodge J, Hansen RM, et al. The rhodopsin content of human eyes. Invest Ophtalmol Vis Sci 1999; 40 (8): 1878-83 (Pubitemid 29297171)
35. Chen W, Hunt DM, Lu H, et al. Expression of antioxidant prospective proteins in the rat retina during prenatal and postnatal development. Invest Ophtalmol Vis Sci 1999; 40 (3): 744-51 (Pubitemid 29109454)
36. Nation RL, Hackett LP, Dusci LJ, et al. Excretion of hydroxychloroquine in human milk. Br J Clin Pharmacol 1984; 17: 368-9 (Pubitemid 14053805)
37. Ostensen M, Brown ND, Chiang PK, et al. Hydroxychloroquine in human breast milk. Eur J Clin Pharmacol 1985; 28 (3): 357 (Pubitemid 15085167)
38. Cissoko H, Jonville-Béra AP, Rouger J, et al. Breast milk concentrations of hydroxychloroquine. Fundam Clin Pharmacol 2010; 24 (Suppl. 1): 420